dr. naumann on data with stro-002 in platinum-resistant/refractory ovarian cancer
Published 4 years ago • 165 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
1:19
dr. naumann on improving outcomes with chemotherapy in ovarian cancer
-
2:25
dr. naumann on unanswered questions with parp inhibitors in ovarian cancer
-
1:09
dr. arend on unmet needs in platinum-resistant ovarian cancer
-
1:19
relacorilant nab-paclitaxel in recurrent, platinum-resistant ovarian cancer
-
14:46
managing platinum-resistant ovarian cancer
-
1:25
dr. matulonis on final data from keynote-100 in recurrent ovarian cancer
-
1:56
dr. maurie markman on the phase iii aurelia trial for platinum-resistant ovarian cancer
-
2:20
dr. matulonis discusses niraparib/pembrolizumab combo in platinum-resistant ovarian cancer
-
1:27
dr. gilbert on evaluating mirvetuximab soravtansine in platinum-agnostic ovarian cancer
-
8:03
bevacizumab in platinum-sensitive ovarian cancer
-
2:18
dr. mirza on final data of the nsgo-avanova2/engot-ov24 trial in ovarian cancer
-
3:10
overview of engot-ov16/nova of niraparib in ovarian cancer and why the results were not surprising
-
1:19
dr. ledermann on phase iii ariel3 results in ovarian cancer
-
1:41
dr. konner on preferred platinum doublets in recurrent ovarian cancer
-
2:14
dr. markman on timing of bso in patients with ovarian cancer
-
1:11
dr. ledermann on the additive effects of olaparib and bevacizumab in ovarian cancer
-
10:22
aravive, inc. - platinum resistant ovarian cancer
-
5:56
approaching platinum-sensitive recurrent ovarian cancer
-
10:11
emerging treatment options for platinum-sensitive ovarian cancer